41. 巨細胞性動脈炎 Disease details / Clinical trials / Drug dev / DR info

17,21-dihydroxypregna-1,4-diene-3,11,20-trione
   Southend Hospital
      2012   -   EUCTR2011-005090-22-GB   United Kingdom
18F-FDG PET/CT
   Svendborg Hospital
      2017   -   NCT02985424   Denmark
18FDG PET scan
   Centre Hospitalier Universitaire Dijon
      2024   Phase 3   NCT06037460   France
3'mrna sequencing
   University of Bonn
      2023   -   NCT06460142   Germany
68-GA HA-dotatate PET/CT
   University of Alberta
      2019   Phase 2   NCT03812302   Canada
Abatacept
   Bristol-Myers Squibb
      2017   Phase 3   NCT03192969   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;Estonia;France;Germany;Greece;Ireland;Italy;Netherlands;Poland;Romania;Serbia;Spain;Sweden;Switzerland;United Kingdom;United States
   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
      2008   Phase 2   NCT00556439   Canada;United States
   University of Pennsylvania
      2021   Phase 3   NCT04474847   Canada;United States
ABT-494
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2019   Phase 3   EUCTR2017-003978-13-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 3   EUCTR2017-003978-13-RO   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-PT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-HU   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-GR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-FR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-ES   Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
   Abbvie GK
      2019   Phase 3   JPRN-jRCT2080224537   Europe;Japan;North America;Oceania
Adalimumab
   Assistance Publique - Hôpitaux de Paris
      2006   Phase 3   NCT00305539   France
Additional blood samples
   Centre Hospitalier Universitaire Dijon
      2024   -   NCT06609668   France
AIN457
   NOVARTIS PHARMA AG
      2021   Phase 3   EUCTR2020-004809-31-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   Novartis Pharma AG
      2023   Phase 3   EUCTR2020-004809-31-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004809-31-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-NO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-FR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
   Novartis Pharma GmbH
      2022   Phase 3   EUCTR2021-002622-24-DE   Germany
      2018   Phase 2   EUCTR2018-002610-12-DE   Germany
Alendronate
   UMC Utrecht
      2000   Phase 3   NCT00138983   Netherlands
Alfacalcidol
   UMC Utrecht
      2000   Phase 3   NCT00138983   Netherlands
Anakinra
   University Hospital, Caen
      2017   Phase 3   NCT02902731   France
Angio-optical coherence tomography
   ASST Fatebenefratelli Sacco
      2024   -   NCT06500728   Italy
ANTI-thymocyte globulin
   Fairview University Medical Center
      2000   -   NCT00006055   United States
Aortic/ cardiac magnetic resonance imaging
   University of Bonn
      2023   -   NCT06460142   Germany
Autologous peripheral blood stem cell transplantation
   Fairview University Medical Center
      2000   -   NCT00006055   United States
Azafol
   Insel Gruppe AG, University Hospital Bern
      2025   Phase 2   NCT06335888   Switzerland
Baricitinib
   Matthew J Koster
      2017   Phase 2   NCT03026504   United States
Blood samples
   Centre Hospitalier Universitaire Dijon
      2024   Phase 3   NCT06037460   France
      2020   Phase 3   NCT03892785   France
      2019   Phase 2   NCT03711448   France
      2017   -   NCT03313102   France
      2015   -   NCT02857192   France
Bosentan
   Assistance Publique - Hôpitaux de Paris
      2025   Phase 2   NCT06957002   France
   University of Edinburgh
      2025   Phase 2   NCT06887062   United Kingdom
Bosentan mylan
   CHU de Nice
      2019   Phase 3   EUCTR2018-004072-35-FR   France
Capsule DI prednisone
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2016   Phase 3   EUCTR2015-001758-14-IT   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
CELL-based EX-vivo assay with HIGH-content analysis
   University of Bonn
      2023   -   NCT06460142   Germany
Cnto 136
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2016   Phase 3   EUCTR2015-001758-14-IT   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
   GlaxoSmithKline Research and Development Limited
      2016   Phase 3   EUCTR2015-001758-14-NL   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001758-14-HU   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001758-14-BG   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-ES   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-DE   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-BE   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
CNTO1959
   JANSSEN CILAG INTERNATIONAL NV
      2020   Phase 2   EUCTR2020-000622-26-IT   Belgium;Canada;France;Germany;Italy;Poland;Spain;United States
   Janssen-Cilag International N.V.
      2021   Phase 2   EUCTR2020-000622-26-DE   Belgium;Canada;France;Germany;Israel;Italy;Poland;Spain;United States
      2021   Phase 2   EUCTR2020-000622-26-BE   Belgium;Canada;France;Germany;Italy;Poland;United States
      2020   Phase 2   EUCTR2020-000622-26-PL   Belgium;Canada;France;Germany;Italy;Poland;United States
      2020   Phase 2   EUCTR2020-000622-26-FR   Belgium;Canada;France;Germany;Italy;Poland;United States
Color fundus photography
   University of Bonn
      2023   -   NCT06460142   Germany
Contrast-enhanced ultrasound
   University of Bonn
      2023   -   NCT06460142   Germany
Cortancyl
   CHU CAEN
      2018   Phase 3   EUCTR2018-000344-25-FR   France
Cortancyl ® 1 MG
   SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT
      2018   Phase 3   EUCTR2017-002988-18-IT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
   Sanofi-Aventis Recherche & Développement
      2019   Phase 3   EUCTR2017-002988-18-SI   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-PT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-HR   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-GB   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-FR   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-FI   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-DK   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-AT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-SE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-NL   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-HU   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-ES   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-EE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-DE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-BE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
Cortancyl ® 20 MG
   SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT
      2018   Phase 3   EUCTR2017-002988-18-IT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
   Sanofi-Aventis Recherche & Développement
      2019   Phase 3   EUCTR2017-002988-18-SI   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-PT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-HR   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-GB   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-FR   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-FI   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-DK   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-AT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-SE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-NL   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-HU   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-ES   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-EE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-DE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-BE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
Cortancyl ® 5 MG
   SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT
      2018   Phase 3   EUCTR2017-002988-18-IT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
   Sanofi-Aventis Recherche & Développement
      2019   Phase 3   EUCTR2017-002988-18-SI   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-PT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-HR   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-GB   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-FR   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-FI   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-DK   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-AT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-SE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-NL   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-HU   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-ES   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-EE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-DE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-BE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
Corticoids+ tocilizumab 8MG/KG/4 weeks
   Centre Hospitalier Universitaire Dijon
      2013   Phase 2   NCT01910038   France
Corticosteroids
   Hoffmann-La Roche
      2013   Phase 3   NCT01791153   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
Corticosteroids FOR systemic USE
   University Hospital, Caen
      2020   Phase 3   NCT04012905   -
Cosentyx
   NOVARTIS PHARMA AG
      2021   Phase 3   EUCTR2020-004809-31-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   Novartis Pharma AG
      2021   Phase 3   EUCTR2020-004809-31-FR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   Novartis Pharma GmbH
      2022   Phase 3   EUCTR2021-002622-24-DE   Germany
      2018   Phase 2   EUCTR2018-002610-12-DE   Germany
Cosentyx 300 MG solution FOR injection IN PRE-filled syringe
   Novartis Pharma AG
      2023   Phase 3   EUCTR2020-004809-31-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004809-31-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-NO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Cosentyx 300MG solution FOR injection IN PRE-filled syringe
   Novartis Pharma AG
      2021   Phase 3   EUCTR2020-004809-31-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Cyclophosphamide
   Fairview University Medical Center
      2000   -   NCT00006055   United States
Cyclosporine
   Fairview University Medical Center
      2000   -   NCT00006055   United States
Data collection FOR correlation between clinical defined and LAB defined GC responsivness
   University Hospital, Basel, Switzerland
      2022   -   NCT05479448   Switzerland
Data collection FOR exploratory analyses OF endogenous steroid hormones
   University Hospital, Basel, Switzerland
      2022   -   NCT05479448   Switzerland
Data collection FOR prednisone metabolism
   University Hospital, Basel, Switzerland
      2022   -   NCT05479448   Switzerland
Encorton
   F. Hoffmann-La Roche Ltd
      2013   Phase 3   EUCTR2011-006022-25-SE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-NL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-IT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-ES   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DK   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-BE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-AT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
   GlaxoSmithKline Research and Development Limited
      2016   Phase 3   EUCTR2015-001758-14-HU   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
Enzyme-linked immunosorbent assay
   University of Bonn
      2023   -   NCT06460142   Germany
FDG
   Insel Gruppe AG, University Hospital Bern
      2025   Phase 2   NCT06335888   Switzerland
Filgrastim
   Fairview University Medical Center
      2000   -   NCT00006055   United States
Flow cytometry
   University of Bonn
      2023   -   NCT06460142   Germany
Fluorescein and indocyanine green angiography
   ASST Fatebenefratelli Sacco
      2024   -   NCT06500728   Italy
Fluorescein angiography
   University of Bonn
      2023   -   NCT06460142   Germany
Fluorine-18
   University Medical Center Groningen, Department of Rheumatology and Clinical Immunology
      2021   Phase 2   EUCTR2020-001019-26-NL   Netherlands
Folate
   University Medical Center Groningen, Department of Rheumatology and Clinical Immunology
      2021   Phase 2   EUCTR2020-001019-26-NL   Netherlands
Functional assessment questionnaires
   University of Bonn
      2023   -   NCT06460142   Germany
Fundus autofluorescence
   University of Bonn
      2023   -   NCT06460142   Germany
Gevokizumab
   Institut de Recherches Internationales Servier (IRIS)
      2015   -   EUCTR2013-002778-38-IE   Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2015   -   EUCTR2013-002778-38-FI   Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2015   -   EUCTR2013-002778-38-EE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2015   -   EUCTR2013-002778-38-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2014   Phase 2   EUCTR2013-002778-38-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2014   -   EUCTR2013-002778-38-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2014   Phase 2   EUCTR2013-002778-38-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2014   -   EUCTR2013-002778-38-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2013   Phase 2   EUCTR2013-002778-38-IT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Italy;Russian Federation;Spain;United Kingdom
   Laboratorios Servier SL
      2014   -   EUCTR2013-002778-38-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Russian Federation;Spain;United Kingdom
Glucocorticoid treatment
   Bristol-Myers Squibb
      2017   Phase 3   NCT03192969   Australia;Austria;Belgium;Bulgaria;Canada;Denmark;Estonia;France;Germany;Greece;Ireland;Italy;Netherlands;Poland;Romania;Serbia;Spain;Sweden;Switzerland;United Kingdom;United States
Glucocorticoids
   Assistance Publique - Hôpitaux de Paris
      2025   Phase 2   NCT06957002   France
   University Hospital Inselspital, Berne
      2018   Phase 1/Phase 2   NCT03745586   Italy;Switzerland
      2011   Phase 2   NCT01450137   Switzerland
GSK2973327
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2016   Phase 3   EUCTR2015-001758-14-IT   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
   GlaxoSmithKline Research and Development Limited
      2016   Phase 3   EUCTR2015-001758-14-NL   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001758-14-HU   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001758-14-BG   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-ES   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-DE   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-BE   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
Guselkumab
   JANSSEN CILAG INTERNATIONAL NV
      2020   Phase 2   EUCTR2020-000622-26-IT   Belgium;Canada;France;Germany;Italy;Poland;Spain;United States
   Janssen Research & Development, LLC
      2020   Phase 2   NCT04633447   Belgium;Canada;France;Germany;Israel;Italy;Poland;Spain;United States
   Janssen-Cilag International N.V.
      2021   Phase 2   EUCTR2020-000622-26-DE   Belgium;Canada;France;Germany;Israel;Italy;Poland;Spain;United States
      2021   Phase 2   EUCTR2020-000622-26-BE   Belgium;Canada;France;Germany;Italy;Poland;United States
      2020   Phase 2   EUCTR2020-000622-26-PL   Belgium;Canada;France;Germany;Italy;Poland;United States
      2020   Phase 2   EUCTR2020-000622-26-FR   Belgium;Canada;France;Germany;Italy;Poland;United States
H02ab09
   Copenhagen University Hospital Rigshospitalet
      2022   Phase 4   EUCTR2021-002528-18-DK   Denmark
HIGH-resolution optical coherence tomography
   ASST Fatebenefratelli Sacco
      2024   -   NCT06500728   Italy
Hydrocortisone
   Copenhagen University Hospital Rigshospitalet
      2022   Phase 4   EUCTR2021-002528-18-DK   Denmark
   Marianne Andersen
      2022   Phase 4   NCT05193396   Denmark
   Ulla Feldt-Rasmussen
      2022   Phase 4   NCT05435781   Denmark
Hydrokortison orion
   Copenhagen University Hospital Rigshospitalet
      2022   Phase 4   EUCTR2021-002528-18-DK   Denmark
Hydroxychloroquine
   University Hospital, Toulouse
      2002   Phase 3   NCT00430807   France
Immunohistochemistry OF temporal artery biopsies
   University of Bonn
      2023   -   NCT06460142   Germany
Infliximab
   Cambridge University Hospitals NHS Foundation Trust
      2021   Phase 2   NCT05168475   United Kingdom
      2020   Phase 2   EUCTR2019-003964-30-GB   United Kingdom
   Centocor, Inc.
      2003   Phase 2   NCT00076726   Belgium;Italy;Spain;United Kingdom;United States
IV steroids combination alone
   Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
      2020   Phase 2   NCT04239196   France
Kineret
   CHU CAEN
      2016   Phase 3   EUCTR2015-005804-27-FR   France
KPL-301
   Kiniksa Pharmaceuticals, Ltd. (Hamilton, Bermuda) c/o Kiniksa Pharmaceuticals Corp.
      2019   Phase 2   EUCTR2018-001003-36-HR   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001003-36-DE   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-SI   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-NL   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-IT   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-GB   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-ES   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-EE   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-BE   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
L04ac07
   Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts
      2019   Phase 2   EUCTR2019-001145-40-FR   France
Lodotra
   Southend Hospital
      2012   -   EUCTR2011-005090-22-GB   United Kingdom
Mavrilimumab
   Kiniksa Pharmaceuticals, Ltd.
      2018   Phase 2   NCT03827018   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
   Kiniksa Pharmaceuticals, Ltd. (Hamilton, Bermuda) c/o Kiniksa Pharmaceuticals Corp.
      2019   Phase 2   EUCTR2018-001003-36-HR   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001003-36-DE   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-SI   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-NL   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-IT   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-GB   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-ES   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-EE   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-BE   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
Methotrexate
   Hoffmann-La Roche
      2013   Phase 3   NCT01791153   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
   The Cleveland Clinic
      1994   Phase 2   NCT00004686   -
   University of Bonn
      2022   Phase 2   NCT05623592   Germany
Methotrexate treatment
   Centre Hospitalier Universitaire Dijon
      2020   Phase 3   NCT03892785   France
Methylprednisolone
   Fairview University Medical Center
      2000   -   NCT00006055   United States
Metoject
   CHU Dijon Bourgogne
      2019   Phase 3   EUCTR2018-002826-22-FR   France
Naltrexone hydrochloride
   University of Pennsylvania
      2019   Phase 2   NCT03482479   Canada;United States
Nivolumab
   Alliance Foundation Trials, LLC.
      2019   Phase 1   NCT03656627   United States
Optical coherence tomography angiography
   University of Bonn
      2023   -   NCT06460142   Germany
Over encapsulated prednisone
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2016   Phase 3   EUCTR2015-001758-14-IT   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
   GlaxoSmithKline Research and Development Limited
      2016   Phase 3   EUCTR2015-001758-14-NL   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001758-14-HU   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001758-14-BG   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-ES   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-DE   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-BE   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
PEG
   University Medical Center Groningen, Department of Rheumatology and Clinical Immunology
      2021   Phase 2   EUCTR2020-001019-26-NL   Netherlands
PET10
   University of Aarhus
      2014   -   NCT03285945   Denmark
PET3
   University of Aarhus
      2014   -   NCT03285945   Denmark
Prednisolon 1 MG jenapharm
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2019   Phase 3   EUCTR2017-003978-13-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 3   EUCTR2017-003978-13-RO   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-PT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-HU   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-GR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-FR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-ES   Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
Prednisolon 10 MG jenapharm
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2019   Phase 3   EUCTR2017-003978-13-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
Prednisolon 20 MG jenapharm
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2019   Phase 3   EUCTR2017-003978-13-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
Prednisolon 5 MG jenapharm
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2019   Phase 3   EUCTR2017-003978-13-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 3   EUCTR2017-003978-13-RO   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-PT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-HU   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-GR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-FR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
Prednisolone
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2019   Phase 3   EUCTR2017-003978-13-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 3   EUCTR2017-003978-13-RO   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-PT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-HU   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-GR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-FR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-ES   Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
   Novartis Pharmaceuticals
      2019   Phase 2   NCT03765788   Germany
   Southend Hospital
      2012   -   EUCTR2011-005090-22-GB   United Kingdom
Prednisone
   Fairview University Medical Center
      2000   -   NCT00006055   United States
   GlaxoSmithKline
      2015   Phase 3   NCT02531633   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States
   Hoffmann-La Roche
      2013   Phase 3   NCT01791153   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
   Insel Gruppe AG, University Hospital Bern
      2026   Phase 3   NCT06833411   Switzerland
   Kiniksa Pharmaceuticals, Ltd.
      2018   Phase 2   NCT03827018   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
   Massachusetts General Hospital
      2018   Phase 4   NCT03726749   United States
      2016   Phase 1/Phase 2   NCT02955147   United States
   NOVARTIS PHARMA AG
      2021   Phase 3   EUCTR2020-004809-31-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   Novartis Pharma AG
      2021   Phase 3   EUCTR2020-004809-31-FR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT
      2018   Phase 3   EUCTR2017-002988-18-IT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
   Sanofi
      2018   Phase 3   NCT03600805   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
   Sanofi-Aventis Recherche & Développement
      2019   Phase 3   EUCTR2017-002988-18-SI   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-PT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-HR   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-GB   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-FR   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-FI   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-DK   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-AT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-SE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-NL   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-HU   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-ES   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-EE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-DE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-BE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
   The Cleveland Clinic
      1994   Phase 2   NCT00004686   -
Prednisone and ustekinumab treatment
   Centre Hospitalier Universitaire Dijon
      2019   Phase 2   NCT03711448   France
Prednisone capsule
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2016   Phase 3   EUCTR2015-001758-14-IT   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
Prednisone capsules
   GlaxoSmithKline Research and Development Limited
      2016   Phase 3   EUCTR2015-001758-14-NL   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001758-14-HU   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001758-14-BG   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-ES   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-DE   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-BE   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
Prednisone tablets USP, 1 MG
   F. Hoffmann-La Roche Ltd
      2013   Phase 3   EUCTR2011-006022-25-SE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-NL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-IT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-GB   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-ES   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DK   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-BE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-AT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
   Novartis Pharma AG
      2023   Phase 3   EUCTR2020-004809-31-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-NO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Prednisone tablets USP, 10 MG
   Novartis Pharma AG
      2023   Phase 3   EUCTR2020-004809-31-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-NO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Prednisone tablets USP, 1MG
   Novartis Pharma AG
      2021   Phase 3   EUCTR2020-004809-31-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Prednisone tablets USP, 2.5 MG
   F. Hoffmann-La Roche Ltd
      2013   Phase 3   EUCTR2011-006022-25-SE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-NL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-IT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-GB   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-ES   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DK   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-BE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-AT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
   Novartis Pharma AG
      2023   Phase 3   EUCTR2020-004809-31-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-NO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Prednisone tablets USP, 2.5MG
   Novartis Pharma AG
      2021   Phase 3   EUCTR2020-004809-31-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Prednisone tablets USP, 20MG
   Novartis Pharma AG
      2021   Phase 3   EUCTR2020-004809-31-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Prednisone tablets USP, 5 MG
   F. Hoffmann-La Roche Ltd
      2013   Phase 3   EUCTR2011-006022-25-SE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-NL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-IT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-GB   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-ES   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DK   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-BE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-AT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
   Novartis Pharma AG
      2023   Phase 3   EUCTR2020-004809-31-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-NO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Prednisone tablets USP, 5MG
   Novartis Pharma AG
      2021   Phase 3   EUCTR2020-004809-31-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Prednisone tablets, USP
   Kiniksa Pharmaceuticals, Ltd. (Hamilton, Bermuda) c/o Kiniksa Pharmaceuticals Corp.
      2019   Phase 2   EUCTR2018-001003-36-HR   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-001003-36-DE   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-SI   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-NL   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-IT   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-GB   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-ES   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-EE   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
      2018   Phase 2   EUCTR2018-001003-36-BE   Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States
Prednisone tablets, USP 10 MG
   Novartis Pharma AG
      2022   Phase 3   EUCTR2020-004809-31-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Prednisone tablets, USP 2.5 MG
   Novartis Pharma AG
      2022   Phase 3   EUCTR2020-004809-31-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Prednisone tablets, USP 5 MG
   Novartis Pharma AG
      2022   Phase 3   EUCTR2020-004809-31-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Prednisone tablets, USP, 1 MG
   Novartis Pharma AG
      2022   Phase 3   EUCTR2020-004809-31-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
Prednisone therapy and pharmacokinetic
   University Hospital, Caen
      2009   Phase 4   NCT01400464   France
Prednisone treatment
   Centre Hospitalier Universitaire Dijon
      2020   Phase 3   NCT03892785   France
      2019   Phase 2   NCT03711448   France
Questionnaires
   Centre Hospitalier Universitaire Dijon
      2024   Phase 3   NCT06037460   France
      2020   Phase 3   NCT03892785   France
      2019   Phase 2   NCT03711448   France
Rituximab
   Cambridge University Hospitals NHS Foundation Trust
      2021   Phase 2   NCT05168475   United Kingdom
      2020   Phase 2   EUCTR2019-003964-30-GB   United Kingdom
RO 001-9265/F02
   F. Hoffmann-La Roche Ltd
      2013   Phase 3   EUCTR2011-006022-25-SE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-NL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-IT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-GB   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-ES   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DK   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-BE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-AT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
RO 001-9265/F03
   F. Hoffmann-La Roche Ltd
      2013   Phase 3   EUCTR2011-006022-25-SE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-NL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-IT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-GB   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-ES   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DK   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-BE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-AT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
RO 001-9265/F04
   F. Hoffmann-La Roche Ltd
      2013   Phase 3   EUCTR2011-006022-25-SE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-NL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-IT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-GB   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-ES   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DK   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-BE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-AT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
RO 487-7533/F10-04
   F. Hoffmann-La Roche Ltd
      2013   Phase 3   EUCTR2011-006022-25-SE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-NL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-IT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-GB   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-ES   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DK   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-BE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-AT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
Roactemra
   CHU Dijon Bourgogne
      2019   Phase 3   EUCTR2018-002826-22-FR   France
   Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts
      2019   Phase 2   EUCTR2019-001145-40-FR   France
   F. Hoffmann-La Roche Ltd
      2013   Phase 3   EUCTR2011-006022-25-NL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-GB   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-ES   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DK   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-BE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-AT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
Roactemra 162 MG solution FOR injection IN PRE-filled syringe
   ROCHE SAS
      2017   Phase 3   EUCTR2016-002716-41-FR   France
Roactemre
   Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts
      2019   Phase 2   EUCTR2019-001145-40-FR   France
S78989
   Institut de Recherches Internationales Servier (IRIS)
      2015   -   EUCTR2013-002778-38-IE   Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2015   -   EUCTR2013-002778-38-FI   Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2015   -   EUCTR2013-002778-38-EE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2015   -   EUCTR2013-002778-38-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2014   Phase 2   EUCTR2013-002778-38-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2014   -   EUCTR2013-002778-38-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2014   Phase 2   EUCTR2013-002778-38-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2014   -   EUCTR2013-002778-38-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2013   Phase 2   EUCTR2013-002778-38-IT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Italy;Russian Federation;Spain;United Kingdom
   Laboratorios Servier SL
      2014   -   EUCTR2013-002778-38-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Russian Federation;Spain;United Kingdom
SAR153191
   SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT
      2018   Phase 3   EUCTR2017-002988-18-IT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
   Sanofi-Aventis Recherche & Développement
      2019   Phase 3   EUCTR2017-002988-18-SI   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-PT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-HR   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-GB   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-FR   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-FI   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-DK   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-AT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-SE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-NL   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-HU   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-ES   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-EE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-DE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-BE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
Sarilumab
   SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT
      2018   Phase 3   EUCTR2017-002988-18-IT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
   Sanofi-Aventis Recherche & Développement
      2019   Phase 3   EUCTR2017-002988-18-SI   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-PT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-HR   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-GB   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-FR   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-FI   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-DK   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2019   Phase 3   EUCTR2017-002988-18-AT   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-SE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-NL   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-HU   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-ES   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-EE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-DE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
      2018   Phase 3   EUCTR2017-002988-18-BE   Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
Sarilumab SAR153191
   Sanofi
      2018   Phase 3   NCT03600805   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States
Secukinumab
   NOVARTIS PHARMA AG
      2021   Phase 3   EUCTR2020-004809-31-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   Novartis Pharma AG
      2023   Phase 3   EUCTR2020-004809-31-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2022   Phase 3   EUCTR2020-004809-31-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-NO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-FR   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
      2021   Phase 3   EUCTR2020-004809-31-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Türkiye;United Kingdom;United States
   Novartis Pharma GmbH
      2022   Phase 3   EUCTR2021-002622-24-DE   Germany
      2018   Phase 2   EUCTR2018-002610-12-DE   Germany
   Novartis Pharmaceuticals
      2024   Phase 1   NCT06130540   Czechia;Italy;Portugal;Spain;Switzerland;United States
Secukinumab 150 MG
   Novartis Pharmaceuticals
      2021   Phase 3   NCT04930094   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
Secukinumab 300 MG
   Novartis Pharmaceuticals
      2022   Phase 3   NCT05380453   Germany
      2021   Phase 3   NCT04930094   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Israel;Italy;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 2   NCT03765788   Germany
Sirukumab
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2016   Phase 3   EUCTR2015-001758-14-IT   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
   GlaxoSmithKline
      2015   Phase 3   NCT02531633   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States
   GlaxoSmithKline Research and Development Limited
      2016   Phase 3   EUCTR2015-001758-14-NL   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001758-14-HU   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001758-14-BG   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-ES   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-DE   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001758-14-BE   Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
Sodium chloride
   University of Bonn
      2022   Phase 2   NCT05623592   Germany
Tocilizumab
   Assistance Publique - Hôpitaux de Paris
      2021   Phase 3   NCT04888221   France
   Cambridge University Hospitals NHS Foundation Trust
      2021   Phase 2   NCT05168475   United Kingdom
      2020   Phase 2   EUCTR2019-003964-30-GB   United Kingdom
   Department of Rheumatology & Clinical Immunology Saitama Medical Center, Saitama Medical Universitity
      2012   -   JPRN-UMIN000008812   Japan
   Hoffmann-La Roche
      2019   Phase 1   NCT03923738   Switzerland
      2017   Phase 3   NCT03202368   France
      2013   Phase 3   NCT01791153   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
   Hospital of Prato
      2015   Phase 4   NCT03244709   Italy
   Massachusetts General Hospital
      2018   Phase 4   NCT03726749   United States
   ROCHE SAS
      2017   Phase 3   EUCTR2016-002716-41-FR   France
   University Hospital Inselspital, Berne
      2018   Phase 1/Phase 2   NCT03745586   Italy;Switzerland
      2011   Phase 2   NCT01450137   Switzerland
Tocilizumab 162MG/0.9ML autoinjector
   Azienda Unità Sanitaria Locale Reggio Emilia
      2020   -   NCT05394909   Italy
Tocilizumab and IV steroids combination
   Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
      2020   Phase 2   NCT04239196   France
Tocilizumab prefilled syringe
   Syneos Health
      2021   Phase 1   NCT04885829   Australia;India;New Zealand
Tocilizumab SC
   F. Hoffmann-La Roche Ltd
      2013   Phase 3   EUCTR2011-006022-25-SE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-PL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-NL   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-IT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-GB   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-ES   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DK   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-DE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-BE   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2011-006022-25-AT   Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States
Tocilizumab treatment
   Centre Hospitalier Universitaire Dijon
      2024   Phase 3   NCT06037460   France
      2020   Phase 3   NCT03892785   France
Transorbital ultrasound
   University of Bonn
      2023   -   NCT06460142   Germany
Treatment
   Centre Hospitalier Universitaire de Nice
      2019   Phase 3   NCT03841734   France
Upadacitinib
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2019   Phase 3   EUCTR2017-003978-13-IT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
   AbbVie
      2019   Phase 3   NCT03725202   Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Japan;Netherlands;New Zealand;Norway;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 3   EUCTR2017-003978-13-RO   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-PT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-NL   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-HU   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-GR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-FR   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-ES   Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-DK   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-DE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-BE   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
      2019   Phase 3   EUCTR2017-003978-13-AT   Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States
   Abbvie GK
      2019   Phase 3   JPRN-jRCT2080224537   Europe;Japan;North America;Oceania
Ustekinumab
   Massachusetts General Hospital
      2016   Phase 1/Phase 2   NCT02955147   United States
Vaccination with 2 doses OF shingrix vaccine
   Region Skane
      2024   Phase 4   NCT06763783   Sweden
Vascular ultrasound
   University of Bonn
      2023   -   NCT06460142   Germany
Vitamin D
   UMC Utrecht
      2000   Phase 3   NCT00138983   Netherlands
Xoma 052
   Institut de Recherches Internationales Servier (IRIS)
      2015   -   EUCTR2013-002778-38-IE   Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2015   -   EUCTR2013-002778-38-FI   Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2015   -   EUCTR2013-002778-38-EE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2015   -   EUCTR2013-002778-38-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2014   Phase 2   EUCTR2013-002778-38-GB   Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2014   -   EUCTR2013-002778-38-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2014   Phase 2   EUCTR2013-002778-38-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2014   -   EUCTR2013-002778-38-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom
      2013   Phase 2   EUCTR2013-002778-38-IT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Italy;Russian Federation;Spain;United Kingdom
   Laboratorios Servier SL
      2014   -   EUCTR2013-002778-38-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Russian Federation;Spain;United Kingdom